Jasper Therapeutics Inc (NAS:JSPR)
$ 0.47 +0.047 (+11.14%) Market Cap: 13.05 Mil Enterprise Value: -340,000.00 PE Ratio: 0 PB Ratio: 3.88 GF Score: 29/100

Jasper Therapeutics Inc To Host an Investor Webinar Meeting Transcript

Dec 02, 2025 / 01:00PM GMT
Release Date Price: $1.58 (-8.14%)
Operator

Thank you for standing by. Welcome to the Jasper Therapeutics Data Update Webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Jasper Investor Relations website following the conclusion of the event.

I'd now like to hand the call over to Jasper's Head of Investor Relations, Alex Gray. Please go ahead, Alex.

Alex Gray
Jasper Therapeutics Inc - Director - Corporate Communications

Thank you, Wilson, and thank you for those listening in today. Joining us for the prepared remarks are Ronald Martell, CEO; Dr. Daniel Adelman, acting CMO; and Dr. Martin Betz, Professor of Dermatology and Allergy at Universitätsmedizin Berlin. Also on the line is Herb Cross, CFO, who will be available during the Q&A session. We will be presenting slides on today's call, which are available via the webinar link and posted to our Investor Relations website.

During today's event, we will be making forward-looking statements based on our estimates and assumptions and our current expectations and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot